Amulet Pharmaceuticals
closedAmulet Pharmaceuticals discovers and develops novel therapeutics to address known liabilities of current therapies serving unmet markets.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
$1.7m | Series A | ||
| Total Funding | 000k | ||
Amulet Pharmaceuticals is a biotechnology company in its early stages, dedicated to creating and advancing new treatments. The company's main focus is on enhancing existing, well-known drugs by incorporating nitric oxide to improve their effectiveness and safety. This approach is applied to develop high-value drugs that can offer better solutions for various medical conditions.
A key area of Amulet's work is the development of a treatment for diabetic gastroparesis, a condition affecting many individuals with diabetes. The company is also working on creating a diverse portfolio of products that cover several therapeutic areas, such as gastrointestinal and respiratory diseases, pain management, blood-related disorders, and infectious diseases. Amulet has a clear business model, centered on the discovery and development of these improved drugs. The company generates revenue through the successful advancement and commercialization of its therapeutic products. Its target clients include patients and healthcare providers who are looking for more effective and safer treatment options than those currently available.
Keywords: biotechnology, nitric oxide, therapeutics, diabetic gastroparesis, drug development, pharmaceuticals, healthcare, medical treatments, life sciences, clinical research